Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition

High-throughput techniques allow for massive screening of drug combinations. To find combinations that exhibit an interaction effect, one filters for promising compound combinations by comparing to a response without interaction. A common principle for no interaction is Loewe Additivity which is bas...

Full description

Bibliographic Details
Main Authors: Simone Lederer, Tjeerd M. H. Dijkstra, Tom Heskes
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00031/full
id doaj-399250e393d143edbb7ec9f16ea71968
record_format Article
spelling doaj-399250e393d143edbb7ec9f16ea719682020-11-24T21:53:32ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-02-01910.3389/fphar.2018.00031319664Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency ConditionSimone Lederer0Tjeerd M. H. Dijkstra1Tjeerd M. H. Dijkstra2Tom Heskes3Institute for Computing and Information Sciences, Radboud University, Nijmegen, NetherlandsMax Planck Institute for Developmental Biology, Tübingen, GermanyCenter for Integrative Neuroscience, University Tübingen, Tübingen, GermanyInstitute for Computing and Information Sciences, Radboud University, Nijmegen, NetherlandsHigh-throughput techniques allow for massive screening of drug combinations. To find combinations that exhibit an interaction effect, one filters for promising compound combinations by comparing to a response without interaction. A common principle for no interaction is Loewe Additivity which is based on the assumption that no compound interacts with itself and that two doses from different compounds having the same effect are equivalent. It then should not matter whether a component is replaced by the other or vice versa. We call this assumption the Loewe Additivity Consistency Condition (LACC). We derive explicit and implicit null reference models from the Loewe Additivity principle that are equivalent when the LACC holds. Of these two formulations, the implicit formulation is the known General Isobole Equation (Loewe, 1928), whereas the explicit one is the novel contribution. The LACC is violated in a significant number of cases. In this scenario the models make different predictions. We analyze two data sets of drug screening that are non-interactive (Cokol et al., 2011; Yadav et al., 2015) and show that the LACC is mostly violated and Loewe Additivity not defined. Further, we compare the measurements of the non-interactive cases of both data sets to the theoretical null reference models in terms of bias and mean squared error. We demonstrate that the explicit formulation of the null reference model leads to smaller mean squared errors than the implicit one and is much faster to compute.http://journal.frontiersin.org/article/10.3389/fphar.2018.00031/fulldose equivalenceexplicit mean equationgeneral isobole equationHill curvenull reference modelresponse surface
collection DOAJ
language English
format Article
sources DOAJ
author Simone Lederer
Tjeerd M. H. Dijkstra
Tjeerd M. H. Dijkstra
Tom Heskes
spellingShingle Simone Lederer
Tjeerd M. H. Dijkstra
Tjeerd M. H. Dijkstra
Tom Heskes
Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
Frontiers in Pharmacology
dose equivalence
explicit mean equation
general isobole equation
Hill curve
null reference model
response surface
author_facet Simone Lederer
Tjeerd M. H. Dijkstra
Tjeerd M. H. Dijkstra
Tom Heskes
author_sort Simone Lederer
title Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
title_short Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
title_full Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
title_fullStr Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
title_full_unstemmed Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
title_sort additive dose response models: explicit formulation and the loewe additivity consistency condition
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-02-01
description High-throughput techniques allow for massive screening of drug combinations. To find combinations that exhibit an interaction effect, one filters for promising compound combinations by comparing to a response without interaction. A common principle for no interaction is Loewe Additivity which is based on the assumption that no compound interacts with itself and that two doses from different compounds having the same effect are equivalent. It then should not matter whether a component is replaced by the other or vice versa. We call this assumption the Loewe Additivity Consistency Condition (LACC). We derive explicit and implicit null reference models from the Loewe Additivity principle that are equivalent when the LACC holds. Of these two formulations, the implicit formulation is the known General Isobole Equation (Loewe, 1928), whereas the explicit one is the novel contribution. The LACC is violated in a significant number of cases. In this scenario the models make different predictions. We analyze two data sets of drug screening that are non-interactive (Cokol et al., 2011; Yadav et al., 2015) and show that the LACC is mostly violated and Loewe Additivity not defined. Further, we compare the measurements of the non-interactive cases of both data sets to the theoretical null reference models in terms of bias and mean squared error. We demonstrate that the explicit formulation of the null reference model leads to smaller mean squared errors than the implicit one and is much faster to compute.
topic dose equivalence
explicit mean equation
general isobole equation
Hill curve
null reference model
response surface
url http://journal.frontiersin.org/article/10.3389/fphar.2018.00031/full
work_keys_str_mv AT simonelederer additivedoseresponsemodelsexplicitformulationandtheloeweadditivityconsistencycondition
AT tjeerdmhdijkstra additivedoseresponsemodelsexplicitformulationandtheloeweadditivityconsistencycondition
AT tjeerdmhdijkstra additivedoseresponsemodelsexplicitformulationandtheloeweadditivityconsistencycondition
AT tomheskes additivedoseresponsemodelsexplicitformulationandtheloeweadditivityconsistencycondition
_version_ 1725871596556517376